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The problem. Bisalbuminemia was investigated in an Iowa 
family by testing for hematological and immunologic abnorma Iities to 
determine associations between bisalbuminemia and connective tissue 
(collagen) and/or autoimmune diseases. Physiochemical properties of 
the anomalous albumin fraction were compared to normal serum albumin. 
Procedure. Cellulose acetate electrophoresis was used to 
determine the genotypes from which was established the genetic pedigree 
of the bisalbumin trait. Sera of family members was screened using the 
following tests: Complete blood count; sedimentation rate; hematocrit; 
antistreptolysin 0 titer; rheumatoid factor; LE preparation; VDRL; 
C-reactive protein and fluorescent anti-nuclear antibody analysis. 
Physiochemical characterization of the anomalous albumin fraction 
included an agar-gel diffusion study and measurement of the relative 
112bi nding abi lity of norma I and abnormal albumins using 5 -thyroxine. 
Findings. Bisalbuminemia was found in seven of fourteen 
members of an Iowa fami Iy and was presumed to have been present in 
one deceased member of the fami Iy. The anoma Iy, transmitted as an 
autosomal codominant, was observed in the heterozygous state. The 
anomalous albumin fraction, albumin B, replaces one-half of the normal 
serum albumin and was found to be an albumin by agar-gel diffusion. 
Tests commonly associated with connective tissue and autoimmune 
diseases failed to show a relationship between the disease groups and 
bi sa Ibuminemia. Addition of 112 5 -thyroxine to bi salbumin sera resulted 
in excess thyroxine binding to albumin B with greater affinity than to 
normal albumin. 
Conclusions. The anomalous albumin B is assumed to be the 
result of a mutation of a gene responsible for the synthesis of normal 
serum albumin. The bisalbuminemia analyzed in this family study 
does not appear to be associated with the connective tissue and/or 
autoimmune diseases or any marked clinical abnormalities. 
AN IMMUNOLOGIC INVESTIGATION OF BISALBUMINEMIA:
 
A GENETICALLY TRANSMITTED SERUM PROTEIN ANOMALY
 
A Thesis
 
Presented to
 
The School of Graduate Studies
 
Drake University
 
In Partial Fulfillment
 
of the Requi rements for the Degree
 
Master of Arts
 
by
 
Lee Stuart Vertuno
 
November 1974
 
d 
&
 
I 
Y 
AN IMMUNOLOGIC INVESTIGATION OF BISALBUMINEMIA:
 
A GENETICALLY TRANSMITTED SERUM PROTEIN ANOMALY
 
by 
Lee Stuart Vertuno 
Approved by Committee: 
Dean of the School 
_.a------------­
TABLE OF CONTENTS
 
PAGE
 
INTRODUCTION AND REVIEW OF THE LITERATURE............ 1
 
MATERIALS AND METHODS 6
 
RESULTS 9
 
DISCUSSION 21
 
SUMMARY AND CONCLUSIONS 25
 
LITERATURE CiTED.... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
 
LIST OF TABLES 
TABLE PAGE 
1.	 Protein concentrations of fami Iy members with
 
double albumin.
 14 
2.	 Protein concentrations of family members with
 
normal albumin.
 15 
3. Hematologic data for family members. 18 
4. Immunochemical test data for fami Iy members.	 19 
LIST OF FIGURES 
FIGURE	 PAGE 
1.	 Agar-gel diffusion precipitation reactions of goat 
anti-human albumin serum and protein 
containing electrophoretic strips. 11 
2.	 Cellulose acetate electrophoresis of sera from the 
family members tested. 12 
3. Genetic pedigree of fami Iy with bi salbuminemia.	 13 
4. Binding of 1125 -thyroxine by normal and 
17bi salbumin sera. 
INTRODUCTION AND REVIEW OF THE LITERATURE 
Bisalbuminemia, first reported by Scheurlen (1955), is an 
unusual serum protein anomaly characterized by the presence of two 
electrophoretically distinct albumins of approximately equal concentra­
tion in the same serum sample. Knedel (1957, 1958) observed the 
anomaly in eight members of two different families. Immunochemical 
studies indicated that both fractions in the albumin region, designated 
Al and A2 by Knedel, were albumin and termed the condition "Double 
Albuminemia". Earle et al. (1958,1959) reported the anomaly in 25 
of 43 members of a single fami Iy designating the two albumin fractions 
A and B. Albumin A, corresponding to Knedel's At, was proven to be 
normal albumin and albumin 8, corresponding to Knedel's A2 , was the 
abnorma I albumin. Paralbuminemia was suggested by Earle et al. as 
preferable to bisalbuminemia, the latter term being appropriate for the 
heterozygous state only. Subsequently, several more families of Euro­
pean descent with slow moving albumin variants were described 
(Wuhrmann, 1959; Franglen et al., 1960; Miescher, 1960; Adner and 
Redfors, 1961; Cooke et aI., 1961; Sarcione and Aungst, 1962; Robbins 
et aI., 1963; Efremov and Braend, 1964; Sandor et al., 1965; Drachman 
et al., 1965; Braend et al., 1965; Ungari and Lopez, 1965; Adams, 
1966; Weitkamp et al., 1966). An additional slow albumin variant 
found in Venezuelan Warao Indians was reported by Arends et al. 
(1969) .
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In addition, several fast moving albumin variants have been 
reported (Wieme, 1960; Tarnoky and Lestas, 1964; Melartin and 
Blumberg, 1966; Bell et al., 1967; Polesky and Rokala, 1967). 
Melartin et al. (1967) found a variant termed Albumin Mexico 
which migrated between the normal albumin and the slow moving vari­
ant most frequently observed in persons of European origin. 
Weitkamp et al. (1967) compared the electrophoretic mobility 
of 19 albumin variants obtained from unrelated families. These 19 vari­
ants were placed in five classes based upon thei r electrophoretic mo­
bi Iity. The slow moving variant from persons of European origin was 
designated as livery slow". The variants described by Sandor et al. 
(1965) and Melartin et al. (1967), presumed to have similar migration 
rates, were called "slow", The fast moving variants were divided into 
three classes. One called "fast" came from a British family described 
by Tarnoky and Lestas (1964). The variants described in North 
American Indians (Melartin and Blumberg, 1966; Bell et al., 1967; 
Polesky and Rokala, 1967) composed the "faster" class. The livery 
fast" category included the albumin described by Wieme (1960). It is 
evident, therefore, that in addition to norma I albumin, there are at 
least five variants that give the appearance of bisa Ibuminemia (i. e. , 
two albumin zones with similar staining intensity). An additional vari­
ant, which does not fit this definition, wi II be considered later. 
Family studies on bisalbuminemia have shown the anomaly to be 
3
 
transmitted genetically as an autosomal codominant characteristic and 
that the double albumin peak in the serum of an individual is a mani­
festation of the heterozygous state. Homozygotes have been reported by 
Melartin and Blumberg (1966) and Bell et al. (1967) in Indian subjects 
exhibiting the IIfaster" type of bisalbumin anomaly. 
Blumberg et al. {1968} suggested the substitution of 
"a ll oa lbuminemia" for IIbisalbuminemia" to indicate albumin variation. 
Such a term could be applied to homozygosity where the term 
bisa Ibuminemia is not appropriate. Furthermore, it would indicate in­
herited variation in a manner analogous with the serologically deter-
I 
L 
mined allotypes (i. e., Gm, Inv and Ag) . !j 
As mentioned earlier, an additional variant albumin exists that 
does not fit the definition of bisalbuminemia. Laurell and Nilehn (19661 
found five of 1550 unrelated orthopedic patients had an unusual albu­
min pattern on agarose gel electrophoresis which was inherited as an 
autosomal codominant trait. The albumin, normal in concentration, con­
sisted of a single broad zone extending cathodically to the alpha 1 
globulin region. The total albumin of the anomalous serum was sepa­
rated into two components chromatographically, one consisting of nor­
mal albumin and the other of a more positively charged component with 
about one-thi rd the norma I albumin concentration. The unusua I com­
ponent reacted immunochemically as albumin. This finding proved that 
the anomaly under study was actually bisalbuminemia, although the 
4
 
electrical charge difference was not sufficient to separate the norma I 
and aberrant protein completely. 
Previous studies have suggested but not proven any disease 
associated with bisalbuminemia. Probands have been described with 
diabetes melliti s (Scheurlen, 1955; Laurell and Ni lehn, 1966); hepatiti s 
(Knedel, 1957); congenital absence of one kidney and ureter with an 
undiagnosed disease of the remaining kidney (Earle et al., 1958, 1959); 
acrocyanosis with hyperkeratosis and joint deformity of fingers and 
toes (Frang len et al., 1960); Wegener's granulomatosis (Sarcione and 
Aungst, 1962); rheumatic fever (Robbins et al., 1963) ~ carcinoma 
(Tarnoky and Lestas, 1964); mitrol stenosis and nephrotic syndrome 
(Weitkamp et aI., 1966); and epilepsy (Tschankov, 1971). Lam"ell and 
Ni lehn (1966) indicated a possible association between bisalbuminemia 
and disease of the supporting tissue after finding five unrelated sub­
jects with anomalous albumins on screening electrophoresis of 1550 sera 
from orthopedic patients but only one person in 3200 control subjects 
that showed the same serum anomaly. One patient was known to have 
systemic lupus erythematosis and the remaining five persons had long 
histories of bone and joint pain and disorders. These included a rup­
tured knee meniscus, recurrent dislocation of a shoulder and back 
pain. A familial study was conducted on one subject which resulted 
in finding nine of 24 family members with bisalbuminemia. All nine 
fami Iy members attested to long histories of joint and bone problems. 
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Blumberg et al. (1968) states that serum albumin is the major 
plasma protein involved in blood transport of cations, anions, dyes, 
drugs and various physiological substances. Several substances bind 
almost exclusively to albumin (i .e., bromophenol blue, fatty acid, 
bi lirubin) and several other substances which bind to other serum pro­
teins also bind to serum albumins. Examples of substances which bind 
to a serum protein in addition to albumin are thyroxine, which binds 
mainly to alpha globulin, and hemoglobin, which binds mainly to 
haptoglobulin. Both of these wi II bind to albumin when they are pres­
ent insufficiently high concentration. Severa I studies have included a 
relative binding investigation between normal and anomalous albumin 
fractions. Franglen et a I. (1960) observed no difference between the 
relative binding ability of normal and bisalbumin to n-tolyl-a­
naphthylamine-8-sulphonic acid and sulfonphthalein dyes. Sarcione and 
Aungst (1962) found that 11S1 -thyroxine bound to albumin B rather than 
albumin A in bisalbumin sera but no difference was observed with 
bromophenol blue and Hg 20 3 labeled Neohydrin. Blumberg et al. 
(1968) found that thyroxine and bromophenol blue bound more readily 
to the "fast" moving albumin variants than to albumin A. The action of 
certain drugs may be altered due to the differential binding between 
albumin variants and therefore may be of clinical significance. 
The present investigation was the resull of finding the 
bi sa Ibumin trait in a 14-year-old ma [e with rheumatoid arthritis. On 
6 
the basis of previous studies it was hypothesized that bisalbuminemla 
was related to a group of connective tissue disorders termed "collagen 
diseases" and/or autoimmune disorders. It was felt that this relation­
ship might be elicited by studies on the serum of affected individuals 
and thei r fami lies, testing for hematological and immunological abnor­
malities that are commonly associated with collagen and autoimmune 
diseases. Characterization of the chemical and physical properties of 
the anomalous albumin were conducted and compared with normal 
albumin. 
MATERIALS AND METHODS 
The index patient, a 14-year-old Caucasian rna Ie, was obta ined 
through the generous cooperation of Jack J. Spevak, M. D. A medical 
history of the subject revealed that initial symptoms occurred at age 11 
'I 
nI,
with a diagnosis of rheumatoid arthritis. Treatment was ongoing at the i!
 
time of this study. The family members were contacted and blood
 
samples were collected from the index patient and 13 additional fami Iy
 
members.
 
Investigation of the hypothesis was conducted in three phases. 
Initially, a geneological study was made using electrophoretic analysis 
to establish the genetic pedigree of the bisalbumin trait. Fami Iy mem­
bers were then screened, hematologically and immunochemically, using 
the following tests: Complete blood count, sedimentation rate, hemato­
crit, antistreptolysin 0 titer (ASO), rheumatoid factor, LE preparation; 
-
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VDRL, C-reactive protein analysis and fluorescent anti-nuclear antibody 
analysis. The final phase of study included a comparative immunodif­
fusion analysis of normal and anomalous albumin and measurement of 
the relative binding abilities of the two albumins incorporating the use 
of 1125 -thyroxine. Detailed descriptions of the above procedures are 
contained in the following paragraphs. 
Cellulose acetate electrophoresis in barbital buffer (pH=8.8, 
ionic strength=0.09) was carried out in the Gelman Seprater system 
using Sepraphore III strips and a Gelman Electrophoresis Chamber 
using Sepraphore III, 1" X 63/4" strips. The sera were separated 
using recommended voltage and time, stained in Ponceau 5 and cleared 
using 10% acetic acid in methanol. Protein fraction percentages were 
determined by scanning with the Gelman Digiscreen Densiometer. 
Total proteins were determined on the Technicon Autoanalyzer 
employing a micro biuret reaction. 
Immunochemical studies were carried out by the agar-gel 
diffusion procedure of Ouchterlony (1949) and modified by Sarcione and 
Aungst (1962). The serum proteins were separated by cellulose acetate 
electrophoresis using barbital buffer as described above. The protein 
areas of the air-dried unstained strips were located by cutting 0.4 cm 
strips from each edge of the cellulose acetate strips and staining wi th 
bromophenol blue. The unstained central segment was then aligned 
within the outet- strips and the protein boundaries marked with pencil. 
8 
The protein areas were cut from the strips, rolled on a curved forceps 
and placed into wells of immunodiffusion plates (Nutritional Biochemicals 
Corp., Cleveland, Ohio). The center well was filled with goat anti­
serum aga inst human albumin; the periphera I wei Is with protein con­
taining cellulose acetate strips were fi lied with 0.85 percent saline. 
The plates were incubated at room temperature (22°-25° C) and were 
photographed after 48 hours of incubation. 
Measurement of the relative thyroxine bi nding abi Ii ties of the 
two albumins was carried out as described by Robbins and Rail (1955) 
and modified by Sarcione and Aungst (1962). Three different concen­
trations of 112 5 -thyroxine (Dyroxin, Mallenkroft) were added to serum; 
the serum was incubated at room temperature for 15 minutes and then 
subjected to electrophoresis on cellulose acetate in barbital buffer (des­
cribed above). Radioautographs of the ai r-dried unstained strips were 
prepared by placing the strips against Kodak X-ray fi 1m for 24-48 
hours prior to developing. The position of the strips with respect to 
the film was marked by punching holes through both strips and film so 
that precise realignment of the subsequently stained strips and the 
developed fi 1m could be achieved. 
Hematocrits, sedimentation rates (Winthrop) and differential 
blood cell counts were performed using standard methods of clinical 
analysi s (Levinson and MacFate, 1969). Blood cel I counts were per­
formed on a Coulter Counter, Coulter Electronics, using recommended 
9 
procedures. 
Reagents and test kits for the Antistreptolysin 0 titration, 
C-reactive protein analysis, rheumatoid arthritis factor analysis and 
VDRL test were obtained from Grand Island Biological Co., Grand Is­
land, N. Y. Procedures used were supplied with materials. 
Fluorescent anti-nuclear antibody analysis was performed at 
Mercy Hospi ta I, Des Moines, Iowa. 
RESULTS 
Agar-gel diffusion. Agar-gel diffusion of proteins A and B 
against goat antiserum to human albumin (Fig. 1, top left) resulted in 
a continuous line of precipitation of equal density which did not cross 
throughout four days of observation. On the same plate, norma! human 
serum t-esulted in a single precipitation line and the alpha 1 globulin 
ft-action (P) was non-reactive with respect to the antiserum. The 
remaining two plates (Fig. i, top right and bottom) iUustrate the re­
activity of the albumin fractions of twelve additional family members to 
goat anU-human albumin serum. 
GeneologkaJ data. The sera of 1ll members of the proband1s 
family wet-e subjected to electrophoresis on cellulose acetate (Fig, 2). 
The doub~e albumin trait was found to be transmitted through the 
mother's family (Fig. 3). The father was not available for testing. In 
addition to the index, six other family members exhibited the trait; the 
mother r an uncle, the grandfather, a great aunt, a great uncle and the 
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great uncle1s son. 
Serum protein concentrations. Those individuals having 
bisa Ibuminemia showed no evidence for an association of the trait 
with any change in total protein, total albumin or protein fraction 
other than albumin (Table 1). The ratio of albumin B to albumin A 
was 1.0 with a range of 0.9 to 1.2. Serum protein concentrations of 
family members with normal albumin are given in Table 2. 
Thyroxine binding. When small amounts of 1125 -thyroxine 
(0.1 and 1.0 ug%) were added to sera I the radioactivity was found al­
most exclusively in the interalpha globulin zone of both normal and 
bisalbumin sera (Fig. 4). When the 1125 -thyroxine concentration was 
increased to 10.0 ug%, the radioactivity was found in both the inter-
alpha and the albumin zones as reported preViously by Robbi ns and 
Rail (1955). However, in bisalbumin sera, although thyroxine binding 
in both the interalpha and albumin zones occurred, the radioactivity 
appears to be bound to albumin B more densely than to the expected 
albumin A when compared to the electrophoretic strips. 
Hematological data. Individuals with bisalbuminemia exhibited 
no significant changes from normal blood va lues for the hematoait, 
sedimentation rate and complete blood counts. Data was not listed for 
subject /1-3 due to an insufficient quantity of blood sample for study. 
Hematocrit values were normal for all subjects tested. Sedimentation 
rates were within normal limits except for subjects 11-9 and IV-l in 
11 
Figure 1. Agar gel diffusion precipi tation reactions of goat 
anti-human albumin serum (center wells) against protein containing 
cellulose acetate strips (peripheral wells). Top left: Albumins A 
and B (subject IV-l), normal serum (NS) and normal alpha 1 globu­
lin (P). Top right and bottom: Albumin fractions of twelve family 
members; A(lI-l), 8(11-2). C(II-5), D(lI-7), E(II-9), F{lII-1), 
G (111-3), H (111-4), 1(111-5), J (111-7), K(IV-2), L(IV-4). 
_ 
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Figure 2. Cellulose Acetate Electrophoresis of sera from the
 
fami Iy members who were tested.
 
A(lI-1), (81[-2), C(II-5), D(II-7), E(II-9), F(lII-1), G(III-3), H(III-4),
 
1(111-5), J (111-7), K(IV-l), L(IV-2), M (IV-3), N (11-3).
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Figure 3. Genetic pedigree of family with bisalbuminemia. 
Solid areas represent individuals having the anomaly. Arrow indicates 
index case with rheumatoid arthritis. 
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Table 1. Protein Concentrations of Fami Iy Members with Double Albumin 
Subject Total Serum 
Protein 
Serum Protein Fractions 
percent total protein 
gm% Albumin Alpha 1 Alpha 2 Beta Gamma Alb. /Glob. 
Ratio 
Albumin 
Ratios 
A 8 A B 
11-1 6.6 33.7 29.8 3.9 9.9 9.4 13.3 1.72 1.0 0.9 
11-3 7. 1 29.0 31.0 4.5 10.3 10.3 14.9 1. 50 1.0 1.1 
11-7 5.3 34.2 30.6 3.5 8.5 10.0 13.0 1. 86 1 .0 0.9 
111-1 8.2 26.7 26.6 2.7 17. 1 13.2 13.7 1. 14 1.0 1.0 
111- 3 7.1 29.4 34.6 4.7 9.9 10.4 10.9 1. 78 1.0 1.2 
111-5 7.2 36.3 32.1 3.6 6.7 6. 1 15. 1 2.17 1.0 0.9 
IV-1 * 6.9 30.2 32.2 3.4 10. 1 10. 1 14.0 1. 66 1.0 1.1 
Mean 6.9 31. 4 31.0 3.7 10.4 9.9 13.6 1. 69 1.0 1.0 
±S.E. 0.3 1.3 1.0 0.3 1.2 0.8 0.5 0.13 
Normal 
Values 
6.2 
to 
8.5 
56.5 
to 
71.1 
3. 1 
to 
5.6 
6.7 
to 
10.3 
6.8 
to 
11. 4 
11.8 
to 
19.3 
1.1 
to 
2.2 
*Index Patient 
+= 
:':;;~;~,~:L',.~ •.~,,~.\-""~ ..,..,­
Table 2. Protein Concentrations of Family Members with Normal Albumin 
Subject Total Serum Serum Protein Fractions Alb.jGlob. 
Protein percent total protein Ratio 
gm% Albumin Alpha 1 Alpha 2 Beta Gamma 
11-2 8.3 52.1 4.2 13.6 14.0 16. 1 1. 09 
11. 5 7.4 58.1 4.5 13.5 13.1 10.08 1. 39 
11-9 6.9 57.0 5.4 13.0 13.0 11.6 1.32 
111-4 6.9 51. 8 8.9 13.1 13.7 12.5 1. 07 
111-7 7.7 62.5 3.7 10.6 8.8 14.4 1. 67 
IV-2 7.0 62.0 5.3 10.0 10.0 12.7 1. 63 
IV-3 7.3 60.7 4.3 10.4 10.4 14.2 1.54 
Mean 7.4 57.7 5. 1 12.0 11.8 13.2 1.39 
±S.E. 0.2 1.7 0.7 0.6 0.8 0.7 0.09 
Normal Values 6.2-8.5 56.5-71.1 3.1-5.6 6.7-10.3 6.8-11 .4 11 .8-19.3 1.1-2.2 
(,J'J 
!Z!!.~':'::::~ 
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which cases the values were above normal. Red blood cell and white 
blood cell counts were normal except for slight leukocytosis exhibited 
in subjects 11-2, 11-5 and 111-1. Differential counts on the subjects 
were within normal limits except for the follOWing. Slight lympho­
cytosi s in subjects 11-2 and IV-3 and slight eosinophi lia in subject 
IV-2. 
Immunochemical test data. Individuals with the bisalbumin 
trait showed no evidence for an association of the trait with any change 
in the LE prep, ASO titer, rheumatoid factor, VORL, C-reactive protein 
or fluorescent anti-nuclear antibody analysis. The LE prep was nega­
tive for all family members. The ASO titer was high for three indi­
viduals, 111-1, 111-5 and IV-1. The rheumatoid factor test, VORL and 
fluorescent anti-nuclear antibody tests were negative for all family 
members. The C-reactive protein test (quantitative) gave positive 
results for all subjects except IV-2 and IV-3 who were both negative. 
High titers were found in family members 11-1, 11-2, 11-3, 11-9, 111-1 
and 111-3. 
Clinical material. Case histories of the family members were 
obtained through personal interview or obtained from individual family 
physicians. Identification numbers refer to the pedigree (Fig. 3). 
Subjects· initials follow ID numbers. 
1-1. E.D.; Deceased. Subject 11-1 provided background of 
diabetes melliti 5 and emphysema. No hi story of bone or joint 
17
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Figure 4. Binding of 1125 -thyroxine (T4 ) by normal 
(N) and bisalbumin [SA) sera. The topmost pair of strips 
show Ponceau 5 staining for localization of the protein fl~actions 
on cellulose acetate. The three pairs of radioautographs 
demonstrate the effects of increasing concentration of 1125 _T4 
on its binding by serum components. 
-

Table 3. Hematologic Data For Family Membel~sr 
Subject Hematocrit Sed. Rate Complete Blood Count 
(percent) mm/hr. R8C WBC Differentials (percent) 
3106 /mm3 mm Neut. Eosin. 8aso. Lymphs. Mono. 
11--1 47 1 5.691 5,997 64 0 1 28 7
 
11-2 41 4 5.118 11 , 525 43 1 2 49 5
 
11-3 
11-5 44 5 5.922 12,519 66 1 1 28 4
 
11-7 44.5 4 5.429 7,729 66 2 0 24 8
 
11-9 44 10 5.180 7,500 70 2 1 18 9
 
111-1 48.5 3 4.792 13,950 76 2 1 16 5
 
111-3 44 0 5.000 8,478 65 5 0 21 9
 
111-4 36 1 5.932 7,842 68 3 2 24 4
 
II 1-5 46 7 5.234 5,264 63 1 1 33 2
 
111-7 52 0 5.345 6,389 50 3 5 37 5
 
IV-1* 40 12 5.483 7,687 60 2 1 33 5
 
IV-2 51 0 5.454 6,448 55 8 1 31 5
 
IV-3 46 0 5.616 6,808 41 5 1 44 9
 
.... 
co 
*Index Patient 
Table 4. Immunochemical Test Data for Family Members 
r 
Subject LE Prep. ASO Titer RAF VDRL C-Reactive F.A.N.A. 
(Todd Units) Protein 
11-1 Negative 125 Negative Non-Reactive 5 Negative 
11-2 Negative 333 Negative Non-Reactive 8 Negative 
11-3 Negative Negative Non-Reactive 5 Negative 
11-5 Negative 250 Negative Non-Reacti ve Negative 
11-7 Negative 500 Negative Non-Reactive Negative 
11-9 Negative 833 Negative Non-Reactive 6 Negative 
111-1 Negative 2500 Negative Non-Reactive 8 Negative 
111-3 Negative 250 Negative Non-Reactive 5 Negative 
111-4 Negative 333 Negative Non-Reactive 2 Negative 
111- 5 Negative 2500 Negative Non-Reactive Negative 
111-7 Negative 625 Negative Non-Reactive Negative 
IV-1 * Negative 2500 Negative Non-Reactive Negative 
IV-2 Negative 166 Negative Non-Reactive Negative Negative 
IV-3 Negative 250 Negative Non-Reactive Negative Negative 
*Index Patient 
<.0 
i~ 
I, 
t'j
I
i
I
1
!
I
I
I 
I
, 
, 
20 
problems. 
1-2. I. D.; Deceased. Subject 11-1 provided information and 
background of tuberculosis. Bone or joint problems were denied. 
11-1. O.D. is a 62-year-old Caucasian male with a 20 to 25 
year hi story of arthriti s affecting most joints. Subject had cancer of 
the lip at age 50 which was surgically excised. Individual appeared 
healthy but complained of chronic arthritis at time of interview. 
Subject exhibits bi salbuminemia. 
[1-2. P. D. is a 59-year-old Caucasian female with slight 
arthritis of ten year duration affecting the digits of both hands. 
Subject in apparent good health at time of interview. 
[1-3. T.D.M. is a 60-year-old healthy female. Bone and joint 
problems were denied and she has the bisalbumin trait. 
11-5. M.C. is a 58-year-old woman with Hodgkin's disease. 
She has no history of joint or bone problems. Prednisone therapy in 
progress. 
11-7. L.D. is a 58-year-old male and denies any pathology. 
He has bi salbuminemia. 
11-9. E.D. is a 54-year-old man recovering from cerebral 
apoplexy. Presently under treatment for above, he denies history of 
bone and joint problems. 
111-1. D.J .C.; a 36-year-old woman who has had, since the 
She has noage of 12 years, diabetes mellitis treated with insulin. 
She exhibitsrena I complications and denies bone or joint symptoms. 
-
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bisalbuminemia. 
111-3. R.D.D. is a healthy 34-year-old man who has 
bisalbuminemia. 
111-4. C. F. is a healthy 34-year-old female. 
111-5. D.O.: No information available from subject but 
bisa Ibuminemia is present. 
111-7. T.D.: No information from subject and he has normal 
serum. 
IV-1. S.C.C. is the proband. He is a 14-year-old male with 
a history of rheumatoid arthritis since age 12 affecting the right wrist, 
right knee and left knee. Initial symptoms were evidenced two weeks 
following rubella immunization. Subject had rheumatic fever at age 9 
years. Tonsils and adenoids were removed at age 4. Sinovectomy on 
right knee performed at age 13 years with good results. No acute 
pathology at time of interview. Cortisone therapy in progress. 
IV-2. R.D.F. is a healthy 14-year-old schoolboy. 
IV-3. R.S.F. is a healthy 12-year-old prepubertal male. 
DISCUSSION 
The abnormal protein observed in the index subject and six 
of his relatives by zone electrophoresis on cellulose acetate was identi­
fied as albumin using an agar-gel diffusion procedure. The modified 
Ouchterlony procedure with goat anti-human albumin serum revealed 
that both albumin A and B reacted in a manner indistinguishable from 
--
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norma I human serum albumin. This observation indicates the identity 
or very close antigenic relaton of albumins A and B to normal serum 
albumin. Electrophoresis revealed no additional abnormalities besides 
the double albumin in the sera tested. Control studies on normal 
human serum provided no evidence for the presence of a second albu­
min with a mobility between norma I albumin and the alpha 1 globulin 
region. 
The genealogical data confirms the genetic transmission of the 
bisalbumin trait during three generations. Each individual with the 
anoma Iy is heterozygous for the characteristic, having both normal and 
abnormal albumin. Thus, affected persons probably received a normal 
gene from one parent and an anomalous gene from the other. All un­
affected individuals of the family probably received a normal gene from 
each of their parents. The term Ilcodominant ll has been suggested be­
cause of the effect of each gene, the normal and abnormal seen in 
heterozygotes {Earle et aI., 1959}. 
The presence of bisalbuminemia was not associated with any 
significant change in the total serum protein, total albumin or serum 
components other than albumin. The ratio of albumin B to albumin A 
in anomalous sera was 1: 1 with a range of 0.9 to 1.2. Total serum 
albumin levels were normal. Earle et al. (1959) reported a similar 
1: 1 ratio for albumins A and B. Also reported by Earle et a1. were 
ratios provided by Knedel (personal communication) of 3: 2, 2: 3, 2: 1 
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and 1: 2. These differences in relative proportion of albumins A and 
B were explained as a variation in the relative effectiveness of the 
mutant gene in different families. The albumin/globulin ratios were 
within normal limits for all subjects with the exception of 11-2 and 
111-4 who had low values. Subject 111-1, the proband's mother, had 
an elevated alpha-2-globulin value which is probably the result of 
an increased alpha-2-macroglobulin or pre-beta-lipoprotein level due 
to diabetes mellitis (Cawley, 1969). Although not statistically sig­
nificant, the anoma lous sera show some minor value changes in mean 
percentage of protein components alpha-l-gfobulin, alpha-2-globutin 
and total serum albumin. These minor percentage variations are not 
evident, however, when values are expressed in gram percent of 
protein in the various sera. 
Study of the comparative binding abi lity of albumins A and B 
and normal serum albumin using 1125 -thyroxine resulted in albumin B 
having a greater affinity to bind 1l25 -thyroxine than did albumin A 
(Cech, personal communication). Normal serum albumin bound excess 
thyroxine in control sera. Sarcione and Aungst (1962) in a binding 
study using 1131 -thyroxine observed similar binding properties for al­
bumins A and B and gave several explanations for the unexpected 
results. The initial speculation was that neither albumin A nor albu­
min B were identical to normal serum albumin. Modifications in the 
amino acid sequence and therefore changes in the number of charged 
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side chain groups occurred or such charge differences resulted in a 
difference in the folding of the polypeptide chains of the albumin 
molecule and resulted in binding property changes. A second pos­
sibi lity was that the amino acid sequence of albumin A is identical to 
normal serum albumin and that other factors influenced the thyroxine 
binding of albumin A. These factors might include the action of vari­
ous buffer systems, such as verona I and barbital, to change binding 
abi lities by displacing binding sites. This explanation could be ruled 
out, however, due to the simultaneous use of normal serum and the 
observation that normal serum albumin always bound the added thyrox­
ine. A third possibility was that the bisalbumin sera contained an in­
hibitor which prevents the binding of added thyroxine to albumin A. 
Blumberg et al. (1968) found similar binding properties for albumin B 
and albumin Reading (a fast type of bisalbuminemia). Thyroxine bind­
ing in albumin Naskapi, a fast type of bisalbuminemia, showed no dif­
ference in binding properties when compared with norma r albumin. 
Hematological and immunochemical tests failed to show an 
association of the bi salbumin tra it with a disease entity. Hematological 
values were within normal limits with the exception of two subjects 
exhibiting slightly elevated values for white blood cell counts and one 
subject having a slight eosinophilia. Immunochemical tests were nega­
tive for the LE prep, rheumatoid factor, VDRL and fluorescent anti­
nuclear antibody analysis. Three subjects showed high ASO titers and 
I 
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all three exhibited the bi salbumin trait. However, this is probably 
a result of recent streptococcal infection when the blood samples were 
collected rather than an affect of the double albumin trait. The pos­
sibi lity does exist though, that persons with bisalbuminemia are more 
susceptible to infection with Streptococcus sp. A single titration is 
not sufficient for thi s evaluation to be made. The C-reactive protei n 
test is indicative of an inflamatory response. The C-reactive protein 
\ 
r	 
appears simultaneously with the onset of inflamatory or malignant 
processes. Twelve family members exhibited positive titers with sev­
eral showing high values. This would seem to indicate recent or acute 
pathology. Diagnosis would require further evaluation of the indi­
viduals. Retrospectively, the high titers may have been the result of 
an influenza epidemic immediately prior to collection of the blood 
samples. 
The present investigation was unabl e to show that the collagen 
diseases or the autoimmune diseases are associated with the bisalbumin 
tra it using the aforementioned hematological and immunologic tests. 
However, it did provide additional characterization of the chemical and 
physical properties of the anomalous albumin and further, provided an 
additiona I family having the bi salbumin trait for study. 
SUMMARY AND	 CONCLUSIONS 
A protein serum anoma Iy, bisalbuminemia, has been found on 
cellulose acetate electrophoresis of the serum proteins in 7 of 14 
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members of a fami Iy and is presumed to have been present in one 
deceased member of the fami Iy. 
The anomaly has been observed in the heterozygous state and 
is transmitted as an autosomal codominant characteristic.,,
I
I 
!' The anoma lous albumin B is assumed to be the result of a 
mutation of a gene responsible for the synthesis of normal serum 
albumin. 
r
I
I
I 
Those individuals having bisalbuminemia showed no evidence 
for an association of the trait with any change in total protein, total 
albumin or protein fraction other than albumin. 
The anomalous albumin fraction replaces one-half of the normal 
serum albumin and by agar-gel diffusion (Ouchterlony) analysis was 
found to be an albumin. 
Addition of 1125 -thyroxine to bisalbumin sera resulted in excess 
thyroxine bindi ng to albumin B with greater affinity than to albumin A. 
Hematological and immunochemical tests commonly used to diagnose 
connective tissue (collagen) and autoimmune di seases did not show a 
relationship between these disease groups and the bisalbuminemia cases in 
this study. Although this relationship was a major finding of this study I 
the possible association of these parameters in other patients cannot be 
ruled out. 
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